These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8659572)

  • 1. A new class of anti-HIV drugs debuts.
    Am J Nurs; 1996 Jul; 96(7):59-63. PubMed ID: 8659572
    [No Abstract]   [Full Text] [Related]  

  • 2. New drugs for HIV infection.
    Med Lett Drugs Ther; 1996 Apr; 38(972):35-7. PubMed ID: 8606677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protease inhibitors-at-a-glance.
    Notes Undergr; 1996 Apr; (no 32):4-5. PubMed ID: 11363449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AIDS drugs lurch towards market.
    Steele F
    Nat Med; 1995 Apr; 1(4):285-6. PubMed ID: 7585051
    [No Abstract]   [Full Text] [Related]  

  • 5. Protease inhibitors.
    Treat Rev; 1996 Aug; (No 22):2-7. PubMed ID: 11363815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [For the first time a combination of 2 protease inhibitors investigated].
    Schenk M
    Dtsch Med Wochenschr; 1996 Aug; 121(34-35):A36. PubMed ID: 8829900
    [No Abstract]   [Full Text] [Related]  

  • 7. Conference looks at HIV drug resistance.
    Chang HE
    GMHC Treat Issues; 1995 Sep; 9(9):6-8. PubMed ID: 11362910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on HIV protease inhibitors.
    Vella S
    AIDS Clin Care; 1995 Oct; 7(10):79-82, 88. PubMed ID: 11362832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matching up ritonavir with saquinavir.
    GMHC Treat Issues; 1996 Apr; 10(4):8. PubMed ID: 11363708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protease inhibitors: ritonavir and saquinavir combination trial recruiting--seven U.S., Canada sites incl. San Francisco.
    AIDS Treat News; 1996 Apr; (no 245):1-3. PubMed ID: 11363621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ritonavir/saquinavir trial announced.
    J Int Assoc Physicians AIDS Care; 1996 Apr; 2(4):59. PubMed ID: 11363522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nipping HIV in the bud.
    Smart T
    GMHC Treat Issues; 1996 Aug; 10(8):3-6. PubMed ID: 11363719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro antiviral activity of 141W94 (VX-478) in combination with other antiretroviral agents.
    St Clair MH; Millard J; Rooney J; Tisdale M; Parry N; Sadler BM; Blum MR; Painter G
    Antiviral Res; 1996 Jan; 29(1):53-6. PubMed ID: 8721545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ritonavir: first to prolong survival.
    MacDougall DS
    J Int Assoc Physicians AIDS Care; 1996 Apr; 2(4):38-44. PubMed ID: 11363517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protease inhibitors show promise in HIV infection.
    Nelson H
    Lancet; 1996 Feb; 347(8998):383. PubMed ID: 8598709
    [No Abstract]   [Full Text] [Related]  

  • 16. FDA approves 2 new protease inhibitors: ritonavir (Norvir) and Crixivan (Indinavir sulfate). Food and Drug Administration.
    Schouten JT
    STEP Perspect; 1996; 8(1):7-8. PubMed ID: 11363592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ritonavir plus saquinavir: two trials with different results.
    Mascolini M
    AIDS Treat News; 1996 Sep; (No 254):5-6. PubMed ID: 11363819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Freedom of choice.
    Vazquez E
    Posit Aware; 1996; 7(3):9, 19. PubMed ID: 11363432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kids studies.
    Treat Rev; 1995 Nov; (no 20):7. PubMed ID: 11363029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two new protease inhibitors approved by FDA. Food and Drug Administration.
    Folkers G
    NIAID AIDS Agenda; 1996 Mar; ():4-5. PubMed ID: 11363799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.